A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer

BMC Cancer

Dirk Rades³  Sarah Douglas⁴  Theo Veninga²  Steven E Schild¹ 

[1] Department of Radiation Oncology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA

[2] Department of Radiation Oncology, Dr. Bernard Verbeeten Institute, Tilburg, Netherlands

[3] Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, d-23538, Lübeck, Germany

[4] Department of Radiation Oncology, University of Lubeck, Lubeck, Germany

关键词: Scoring system;    Survival prognosis;    Radiotherapy;    Metastatic spinal cord compression;    Non-small cell lung cancer;   

Others  :  1080305
DOI  :  10.1186/1471-2407-12-302

 received in 2012-04-16, accepted in 2012-07-20,  发布年份 2012

【 摘 要 】

Background

This multicenter study aimed to create and validate a scoring system for survival of patients with metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC).

Methods

The entire cohort of 356 patients was divided in a test group (N = 178) and a validation group (N = 178). In the test group, nine pre-treatment factors including age, gender, Eastern Cooperative Oncology Group performance status (ECOG-PS), number of involved vertebrae, pre-radiotherapy ambulatory status, other bone metastases, visceral metastases, interval from cancer diagnosis to radiotherapy of MSCC, and the time developing motor were retrospectively analyzed.

Results

On multivariate analysis, survival was significantly associated with ECOG-PS, pre-radiotherapy ambulatory status, visceral metastases, and the time developing motor deficits. These factors were included in the scoring system; the score for each factor was determined by dividing the 6-month survival rate (in %) by 10. The risk score represented the sum of the scores for each factor. According to the risk scores, which ranged from 6 to 19 points, three prognostic groups were designed. The 6-month survival rates were 6% for 6–10 points, 29% for 11–15 points, and 78% for 16–19 points (p < 0.001). In the validation group, the 6-month survival rates were 4%, 24%, and 76%, respectively (p < 0.001).

Conclusions

Since the survival rates of the validation group were similar to those of the test group, this score can be considered reproducible. The scoring system can help when selecting the individual treatment for patients with MSCC from NSCLC. A prospective confirmatory study is warranted.

【 授权许可】

   
2012 Rades et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Prasad D, Schiff D: Malignant spinal cord compression. Lancet Oncol 2005, 6:15-24.
• [2]Patchell R, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B: Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366:643-648.
• [3]Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE: Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006, 24:3388-3393.
• [4]Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE: Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2011, 79:524-530.
• [5]Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S: Scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 1990, 15:1110-1113.
• [6]Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J: A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005, 30:2186-2191.
• [7]Bauer HC, Wedin R: Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 1995, 66:143-146.
• [8]Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, Rehak P, Windhager R: Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 2008, 17:1488-1495.
• [9]Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T: Surgical strategy for spinal metastases. Spine 2001, 26:298-306.
• [10]Van der Linden YN, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW: Pediction of survival in patients with metastases in the spinal column: results based on a arandomized trial of radiotherapy. Cancer 2005, 103:320-328.
• [11]Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE: Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005, 23:3366-3375.
• [12]Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJA, Hoskin PJ, Rudat V, Schild SE: Metastatic spinal cord compression in non-small cell lung cancer patients: Prognostic factors in a series of 356 patients. Strahlenther Onkol 2012. in press
• [13]Glare PA, Eychmueller S, McMahon P: Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin Oncol 2004, 23:4823-4828.
• [14]Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I: Predictive model for survival in patients with advanced cancer. J Clin Oncol 2008, 26:5863-5869.
• [15]Rades D, Dunst J, Schild SE: The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer 2008, 112:157-161.
• [16]Tokuhashi Y, Ajiro Y, Umezawa N: Outcome of treatment for spinal metastases using scoring systems for preoperative evaluation of prognosis. Spine 2009, 34:69-73.
• [17]Arrigo RT, Kalanithi P, Cheng I, Alamin T, Carragee EJ, Mindea SA, Park J, Boakye M: Predictors of survival after surgical treatment of spinal metastasis. Neurosurgery 2011, 68:674-681.
• [18]Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.